Impact of 2-deoxy-D-glucose on the target metabolome profile of a human endometrial cancer cell line

Biomedical Research (Japan)

Volumn 34, Issue 5, 2013, Pages 221-229

  Urakami, Kenichi ^a   Zangiacomi, Vincent ^a   Yamaguchi, Ken ^a   Kusuhara, Masatoshi ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 DEOXY DEXTRO GLUCOSE 6 PHOSPHATE; DEOXYGLUCOSE; GLUCOSE 6 PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CAPILLARY ELECTROPHORESIS; CELL METABOLISM; CONTROLLED STUDY; ENDOMETRIUM CANCER; GLYCOLYSIS; HUMAN; HUMAN CELL; METABOLOMICS; TIME OF FLIGHT MASS SPECTROMETRY;

CELL LINE, TUMOR; DEOXYGLUCOSE; ENDOMETRIAL NEOPLASMS; FEMALE; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS;

EID: 84887070491     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.34.221     Document Type: Article

References (33)

1. Achari A, Marshall SE, Muirhead H, Palmieri RH and Noltmann EA (1981) Glucose-6-phosphate isomerase. Philos Trans R Soc Lond B Biol Sci 293, 145-157.
2. Ben Sahra I, Laurent K, Giuliano S, Larbret F, Ponzio G, Gounon P, Le Marchand-Brustel Y, Giorgetti-Peraldi S, Cormont M, Bertolotto C, Deckert M, Auberger P, Tanti JF and Bost F (2010) Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res 70, 2465-2475.
3. Chabanon H, Persson L, Wallace HM, Ferrara M and Brachet P (2000) Increased translation efficiency and antizymedependent stabilization of ornithine decarboxylase in amino acid-supplemented human colon adenocarcinoma cells, Caco-2. Biochem J 348, 401-408.
4. Demetrakopoulos GE, Linn B and Amos H (1982) Starvation, deoxy-sugars, ouabain, and ATP metabolism in normal and malignant cells. Cancer Biochem Biophys 6, 65-74.
5. Dwarakanath BS, Singh D, Banerji AK, Sarin R, Venkataramana NK, Jalali R, Vishwanath PN, Mohanti BK, Tripathi RP, Kalia VK and Jain V (2009) Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects. J Cancer Res Ther 5, S21-S26.
6. Heminger K, Jain V, Kadakia M, Dwarakanath B and Berberich SJ (2006) Altered gene expression induced by ionizing radiation and glycolytic inhibitor 2-deoxy-glucose in a human glioma cell line: implications for radio sensitization. Cancer Biol Ther 5, 815-823.
7. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, Esumi H and Soga T (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69, 4918-4925.
8. Hunter AJ and Blekkenhorst GH (1998) The effects of 2-deoxyglucose and amino-oxyacetic acid on the radiation response of mammalian cells in vitro. Int J Radiat Biol 73, 311-324.
9. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ (2008) Cancer statistics, 2008 CA Cancer J Clin 58, 71-96.
10. Jones SC, Alavi A, Christman D, Montanez I, Wolf AP and Reivich M (1982) The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. J Nucl Med 23, 613-617.
11. Kanazawa Y, Yamane H, Shinohara S, Kuribayashi S, Momozono Y, Yamato Y, Kojima M and Masuda K (1996) 2-Deoxy-2-fluoro-D-glucose as a functional probe for NMR: the unique metabolism beyond its 6-phosphate. J Neurochem 66, 2113-2120.
12. Kanazawa Y, Umayahara K, Shimmura T and Yamashita T (1997) 19F NMR of 2-deoxy-2-fluoro-D-glucose for tumor diagnosis in mice. An NDP-bound hexose analog as a new NMR target for imaging. NMR Biomed 10, 35-41.
13. Klukas C and Schreiber F (2010) Integration of-omics data and networks for biomedical research with VANTED. J Integr Bioinform 7, 112-117.
14. Kroemer G and Pouyssegur J (2008) Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13, 472-482.
15. Kuramoto H, Hamano M and Imai M (2002) HEC-1 cells. Hum Cell 15, 81-95.
16. Kurtoglu M, Gao N, Shang J, Maher JC, Lehrman MA, Wangpaichitr M, Savaraj N, Lane AN and Lampidis TJ (2007) Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation. Mol Cancer Ther 6, 3049-3058.
17. Lin X, Zhang F, Bradbury CM, Kaushal A, Li L, Spitz DR, Aft RL and Gius D (2003) 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res 63, 3413-3417.
18. Minami Y, Kasukawa T, Kakazu Y, Iigo M, Sugimoto M, Ikeda S, Yasui A, van der Horst GT, Soga T and Ueda HR (2009) Measurement of internal body time by blood metabolomics. Proc Natl Acad Sci USA 106, 9890-9895.
19. Meyerhof O (1927) Ueber die enzymatische Milch-saurebildung im Muskelextrakt; die Milch-saurebildung aus den garfahigen Hexosen. Biochem Z 183, 176-215.
20. Ohashi Y, Hirayama A, Ishikawa T, Nakamura S, Shimizu K, Ueno Y, Tomita M and Soga T (2008) Depiction of metabolome changes in histidine-starved Escherichia coli by CETOFMS. Mol Biosyst 4, 135-147.
21. Ooga T, Ohashi Y, Kuramitsu S, Koyama Y, Tomita M, Soga T and Masui R (2009) Degradation of ppGpp by nudix pyrophosphatase modulates the transition of growth phase in the bacterium Thermus thermophilus. J Biol Chem 284, 15549-15556.
22. Ramautar R, Mayboroda OA, Somsen GW and de Jong GJ (2011) CE-MS for metabolomics: Developments and applications in the period 2008-2010. Electrophoresis 32, 52-65.
23. Ralser M, Wamelink MM, Struys EA, Joppich C, Krobitsch S, Jakobs C and Lehrach H (2008) A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth. Proc Natl Acad Sci USA 105, 17807-17811.
24. Rodríguez-Enríquez S, Marín-Hernández A, Gallardo-Pérez JC, Carreño-Fuentes L and Moreno-Sánchez R (2009) Targeting of cancer energy metabolism. Mol Nutr Food Res 53, 29-48.
25. Soga T, Ohashi Y, Ueno Y, Naraoka H, Tomita M and Nishioka T (2003) Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J Proteome Res 2, 488-494.
26. Sugimoto M, Hirayama A, Robert M, Abe S, Soga T and Tomita M (2010) Prediction of metabolite identity from accurate mass, migration time prediction and isotopic pattern information in CE-TOFMS data. Electrophoresis 31, 2311-2318.
27. Thakkar NS and Potten CS (1993) Inhibition of doxorubicininduced apoptosis in vivo by 2-deoxy-D-glucose. Cancer Res 53, 2057-2060.
28. Urakami K, Zangiacomi V, Yamaguchi K and Kusuhara M (2010) Quantitative metabolome profiling of Illicium anisatum by capillary electrophoresis time-of-flight mass spectrometry. Biomed Res 31, 161-163.
29. Ushijima K (2009) Current status of gynecologic cancer in Japan. J Gynecol Oncol 20, 67-71.
30. Vander Heiden MG, Cantley LC and Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033.
31. Warburg O, Posener K and Negelein E (1924) Über den Stoffwechsel der Carcinomzelle. Biochem Z 152, 309-344.
32. Warburg O (1956) On the origin of cancer cells. Science 123, 309-314.
33. Zhong D, Liu X, Schafer-Hales K, Marcus AI, Khuri FR, Sun SY and Zhou W (2008) 2-Deoxyglucose induces Akt phosphorylation via a mechanism independent of LKB1/ AMP-activated protein kinase signaling activation or glycolysis inhibition. Mol Cancer Ther 7, 809-817.